Purpose: Evidence on the efficacy and safety of complementary and alternative medicine (CAM) for the prevention and treatment of upper-respiratory-tract infection (URTI) in children is reviewed.
An unidentified virus has been reported in regions across Russia, with patients exhibiting persistent high fever and severe ...
Recent study findings suggest that increased genetically predicted uromodulin levels are associated with a lower risk for upper urinary tract infections ... to find new treatment strategies.
A clinical trial shows that a specific probiotic blend reduced fever duration by 48 hours in children with respiratory ...
In recent weeks, I have received calls, texts, and WhatsApp messages from several understandably concerned parents about ...
Findings from a 2023 randomized controlled trial conducted in healthy university students found that taking bovine colostrum ...
The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
A new drug application for povorcitinib is expected to be filed in late 2025 to early 2026 to treat adult patients with ...
Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of age and older ...
Harmony Biosciences Holdings, Inc. , today announced the appointment of Adam Zaeske as Executive Vice President and Chief Commercial Officer (CCO), effective March 31, 2025. The company's current CCO, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback